查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095651

鞘內幫浦市場－2026-2032年全球市場預測

Intrathecal Pumps Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，鞘內泵市場將成長至 5.7314 億美元，複合年成長率為 5.43%。

主要市場統計數據
基準年 2025 3.9576億美元
預計年份：2026年 4.1622億美元
預測年份 2032 5.7314億美元
複合年成長率 (%) 5.43%

鞘內幫浦執行摘要

鞘內幫浦（IMP）是一種可植入式藥物輸送系統，旨在將藥物直接輸送到腦脊髓液中，與許多全身療法相比，能夠以顯著更低的劑量進行標靶治療。當口服、經皮或注射治療效果不佳、耐受性差或副作用難以接受時，鞘內幫浦主要用於治療嚴重的慢性疼痛和嚴重痙攣。鞘內幫浦生態系統包括可植入式可程式設計程式幫浦、導管、補充裝、臨床程式設計器、已通過核准的藥物製劑、手術植入流程、長期監測和植入後維護。市場需求受到精準疼痛管理、神經復健、控制癌症相關疼痛以及可能減少對高劑量全身性鴉片類藥物依賴的替代療法的臨床需求的影響。此療法的推廣應用與以下因素密切相關：獲得專科醫生、保險報銷機制、感染控制標準、醫療設備安全監測以及疼痛專家、神經外科醫生、康復醫生、藥劑師和護理團隊之間的多學科協作。隨著醫療保健系統優先考慮個人化醫療和長期疾病管理，鞘內藥物輸送正日益成為一種針對經過精心挑選的難治性疾病患者的特殊但具有重要臨床意義的治療選擇。

脊髓內幫浦領域的變革性變化

鞘內幫浦的格局正因多種因素的共同作用而發生重塑：精準給藥、鴉片類藥物的合理使用、數位化醫療的整合以及對醫療設備長期安全性的更高期望。臨床實踐正從廣泛的症狀管理轉向個人化的治療選擇，患者篩檢、試用、幫浦程序設定和持續劑量最佳化成為治療效果的關鍵。可程式設計幫浦能夠根據症狀模式、功能目標和耐受性調整輸注方案，從而為慢性疼痛和嚴重痙攣提供更細緻的護理。同時，醫療專業人員更重視手術技巧、導管置入的精準性、補充藥物的安全性、感染控制和不利事件報告，以減少戒斷症狀、過量用藥、肉芽腫形成、導管功能障礙和醫療設備相關感染疾病等併發症。對植入式醫療設備的監管和臨床審查正在推動更嚴格的上市後監測和臨床醫生培訓。此外，目前的情況正朝著整合式護理路徑發展，將植入手術與物理復健、藥物管理、心理健康支持和系統性追蹤相結合。這些變化正使鞘內治療從以醫療設備為中心的干預措施轉向以病人選擇、安全性、依從性和可衡量的功能改善為重點的長期照護模式。

人工智慧對鞘內幫浦的累積影響

人工智慧 (AI) 正透過臨床決策支援、工作流程最佳化、預測性維護理念和數據驅動的病患監測，開始影響鞘內泵生態系統。雖然 AI 驅動的自主給藥尚未成為標準臨床實踐，但檢驗的分析方法可以透過幫助臨床醫生識別疼痛評分、痙攣評估、補藥間隔、不利事件報告和藥物使用方面的模式，從而支持更安全、更有效率的護理。 AI 驅動的影像和手術規劃工具可以透過輔助解剖評估和導管置入策略，提高手術的準確性，尤其是在複雜的脊椎和神經系統病例中。預測分析還可以幫助護理團隊識別有補藥遺漏風險、潛在用藥不足或過量風險的患者，以及因合併症或複雜用藥方案而需要更密切監測的患者。在醫院營運中，AI 可以簡化幫浦的補藥安排、植入式醫療設備和無菌耗材的庫存規劃以及文件工作流程。然而，人工智慧的影響必須在嚴格的臨床管治、網路安全、互通性和法律規範內進行解讀。由於鞘內治療涉及在靠近中樞神經系統的位置使用高風險藥物，人工智慧應作為臨床判斷的補充，而非替代。短期內，其最有價值的作用並非在於無人監督的治療協調，而在於決策支援、監測、遠端監控和品質改善。

關於鞘內幫浦的關鍵區域見解

在北美，尤其是美國和加拿大，成熟的疼痛管理和神經調控基礎設施、完善的專家網路以及對降低鴉片類藥物風險的高度重視，促進了鞘內泵的廣泛應用。儘管複雜的報銷制度和嚴格的文件要求影響了患者的就醫，但受監管藥物的安全規程、處方箋更新和設備追蹤仍然是推廣應用的關鍵。在歐洲，鞘內治療透過專科中心、復健計畫和國家醫療技術評估流程得到系統性應用。西歐國家強調臨床有效性、成本效益和長期安全性。在亞太地區，隨著日本、澳洲、韓國、中國和印度等擁有完善醫院體系的國家的醫療資源日益豐富，先進的植入式療法也越來越普及。然而，由於報銷制度、專家資源、都市區醫療資源差異以及公立和私立醫療機構的能力等因素，鞘內治療的普及程度有顯著差異。在拉丁美洲，鞘內幫浦的應用正逐步透過三級醫療機構和專業疼痛治療中心推廣，其中巴西和墨西哥發揮關鍵作用。然而，成本效益、採購限制以及神經外科專業技術資源分配不均等問題影響其應用。在中東，大量投資改善了醫院基礎設施，並擴大了專科醫療服務範圍，尤其是在那些擁有完善醫療技術採購計畫的國家。但臨床應用取決於訓練有素的多學科團隊的配備以及持續的追蹤。在非洲，鞘內幫浦的應用仍然有限，目前僅在一些都市區的轉診機構進行。其面臨的障礙包括設備成本高昂、專業醫護人員短缺、維護物流、長期補充服務不足。在所有地區，最有利於鞘內泵應用的環境是那些具備專業植入能力、可靠的藥物供應、保險報銷支持、病患監測以及系統性術後護理的地區。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協地區，鞘內幫浦的普及受到成員國醫療基礎設施差異的影響，更先進的部署集中在能夠進行神經外科手術、疼痛治療、復健和醫療設備維護的三級醫療機構。海灣合作理事會（GCC）國家在先進的急救醫療基礎設施、醫療技術採購和專科醫療投資方面展現出較高的準備度，並且在訓練有素的臨床醫生和長期藥物輸送方案的支持下，為植入式藥物輸送療法的推廣創造了有利條件。歐盟提供了一個監管完善且以實證醫學為基礎的環境，醫療設備安全性、臨床評估、上市後監測和醫療技術評估都會影響鞘內治療的普及。統一的醫療設備法規也提高了對可追溯性和安全性文件的期望。在金磚國家，鞘內幫浦的普及情況各不相同。中國和印度正在擴展先進的醫院功能和專科醫療服務，巴西則透過其大規模的三級醫療體系支援鞘內泵的普及，而俄羅斯和南非則在普及方面存在與地域、採購和醫療服務能力相關的差異。七國集團（G7）國家通常擁有最全面的專家網路、報銷機制、法律規範和臨床研究基礎設施，使其成為鞘內泵方案、安全標準和循證醫學證據生成的重要參考環境。北約成員國與高所得的北美和歐洲醫療保健體系高度重合，這些國家軍人和退伍軍人的醫療需求、創傷復健、慢性疼痛管理和神經損傷護理進一步凸顯了先進植入式療法的重要性。在這些經濟和地緣政治區域，植入式療法的部署更依賴訓練有素的醫療團隊、可靠的醫療設備維護、藥物管理以及終身追蹤的組織能力，而非一般民眾的需求。

各國對鞘內幫浦的重點了解

美國擁有先進的疼痛醫學、神經外科和復健網路，並高度重視鴉片類藥物的使用和植入式醫療設備的安全性，這為鞘內幫浦的應用提供了重要的臨床環境。在加拿大，鞘內治療已納入公共醫療體系，其轉診途徑至專科醫生、省級醫保覆蓋範圍以及多學科疼痛管理項目等因素的影響。在墨西哥和巴西，鞘內泵的應用正透過三級醫療機構和私立專科中心不斷擴展，但醫保報銷的差異以及醫療設備的高昂成本限制了其更廣泛的普及。在英國，鞘內幫浦主要用於疼痛和痙攣專科服務，循證轉診、臨床管治和醫療系統資源分配至關重要。在德國和法國，在先進的醫院基礎設施、復健醫學和嚴格監管的支持下，鞘內泵的系統性應用正在穩步推進。在義大利和西班牙，鞘內泵已在疼痛和神經科專科領域得到應用，但其普及程度取決於當地的醫療管理和醫院採購流程。在俄羅斯，大型醫療中心擁有先進的神經外科和神經內科診療能力，但地域範圍和醫療體系的差異可能會影響後續觀察的連續性。在中國，隨著大型都市區醫院和專科科室的普及，先進的植入式技術正得到更廣泛的應用。同時，在印度，植入式技術的應用主要集中在大型私立和大學附屬醫療機構，成本效益、臨床醫生的專業水平和認知度仍然是決定性因素。在日本，高度發展的醫療設備系統和老齡化社會的需求推動了先進的疼痛和痙攣管理，並高度重視安全性和臨床品質。在澳大利亞，雖然專業的疼痛管理服務和系統的醫療監管系統具有優勢，但地域性和區域性差異可能會影響追蹤的發展。韓國憑藉其先進的醫院系統、數位醫療應對力和強大的外科手術能力，支持在複雜疼痛和痙攣病例中選擇性地使用鞘內泵。在所有國家，成功的鞘內幫浦計畫都需要合適的病患選擇、經驗豐富的植入團隊、可靠的藥物替代途徑、不利事件監測以及醫院和門診之間的協調。

為行業領導者提供的實用建議

產業領導者應將臨床安全、病患選擇和長期照護連續性作為鞘內幫浦策略的核心支柱。製造商和相關人員應投資於臨床醫生教育，內容涵蓋植入技術、導管管理、幫浦編程、藥物補充準確性、感染預防以及過量用藥和戒斷症狀的緊急應變。產品開發應著重於可靠性、易用性、安全的程式功能、補充藥物期間的安全特性以及與支援用藥依從性和追蹤的數位監測系統的兼容性，同時確保網路安全。相關人員應透過真實世界結果、註冊登記、併發症追蹤和病患報告指標來加強證據生成，以證明功能改善、生活品質提高、藥物劑量減少以及護理路徑效率提升。醫療保健系統應制定標準化的鞘內治療護理路徑，包括心理篩檢、試驗方案、多學科會診、知情同意、藥物補充計劃和緊急時應對計畫。在新興市場，領導者應透過培訓夥伴關係、確保藥物補充連續性的服務模式以及與醫院容量相符的籌資策略來解決進入障礙。監管和品管團隊應維持健全的上市後監測、可追溯性和不利事件通報機制。商業策略應避免過度推廣該療法，而應重點關注高需求、臨床適用的患者群體，在這些群體中，在專家指導下進行靶向鞘內給藥能夠帶來可衡量的獲益。

調查方法

分析鞘內幫浦現狀的調查方法應結合臨床證據審查、監管評估、醫療系統評估和專家檢驗。主要研究應包括對疼痛專家、神經外科醫生、復健醫師、藥劑師、採購經理、臨床工程師以及參與幫浦補充和病患監測的護理團隊進行結構化訪談。次要研究應參考同儕審查的醫學文獻、臨床指南、監管安全資訊、醫療設備分類文件、醫院規程、報銷政策、公共衛生數據和不利事件報告系統。區域和國家層級的分析應評估專家資源、手術基礎設施、管制藥物控制系統、報銷途徑、植入後追蹤系統以及病患就醫障礙。數據檢驗對於檢驗來自臨床、監管、營運和醫療服務等資訊來源的研究結果至關重要。此調查方法應消除無根據的假設，避免依賴市場標語，而是強調關於安全性、有效性、工作流程和部署條件的檢驗證據。由於鞘內治療涉及植入式醫療設備和高風險藥物，評估應特別關注併發症、風險緩解、更換物流、程序管理和長期監測。隨著醫療設備法規、數位醫療整合、臨床指南和鴉片類藥物合理使用政策的不斷發展，建議持續進行審查。

結論

鞘內幫浦在現代疼痛和痙攣管理中發揮著特殊而關鍵的作用，它能夠為病情嚴重且難治的患者提供精準的藥物輸送。隨著程式功能的改進、安全性的提高、多學科診療路徑的建構以及對數位化和人工智慧驅動的監測日益成長的興趣，該領域正在不斷進步。區域部署高度依賴專家知識、報銷機制、醫院基礎設施、藥物管理以及提供可靠的長期追蹤的能力。雖然高所得國家通常擁有更成熟的部署環境，但如果能夠確保培訓、成本效益和服務連續性，新興地區也蘊藏著巨大的機會。最永續的路徑是在專家臨床指導下，基於實證醫學，將鞘內幫浦應用於最有可能獲益的患者，而不是盲目擴張。優先考慮安全性、真實世界數據、互通性、臨床醫生培訓和以患者為中心的護理的行業領導者，將更有能力支持鞘內藥物傳遞的穩健發展。隨著醫療保健系統不斷尋求針對複雜疼痛和神經系統疾病的先進替代療法，鞘內泵仍將是先進的多學科治療策略中的關鍵技術。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 鞘內幫浦市場：依泵浦類型分類

  • 外置泵
  • 嵌入式泵浦
    • 可程式設計
    • 恆定流量

第8章 鞘內幫浦市場：依藥物類型分類

  • Baclofen類藥物
  • 非鴉片類鎮痛藥
  • 鴉片類藥物治療
  • 多重藥物合併治療

第9章 鞘內幫浦市場：依儲液槽容量分類

  • 少於 20 毫升
  • 20毫升至不足30毫升
  • 30毫升至少於40毫升
  • 40毫升或更多

第10章 鞘內幫浦市場：依治療領域分類

  • 疼痛管理
    • 癌症疼痛
    • 慢性非癌性疼痛
  • 痙攣管理
    • 腦性麻痹
    • 多發性硬化症
    • 脊髓損傷

第11章 鞘內幫浦市場：依手術類型分類

  • 篩檢測試程序
  • 新的植入技術
  • 更換程序
  • 再次手術
  • 切除手術

第12章 鞘內幫浦市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章 鞘內幫浦市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 鞘內幫浦市場：依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第15章 鞘內幫浦市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 法國
  • 加拿大
  • 澳洲
  • 巴西
  • 義大利
  • 墨西哥
  • 韓國
  • 俄羅斯
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CODAN Medizinische Gerate GmbH & Co KG
  • Eitan Medical Ltd.
  • Epimed International, Inc.
  • ICU Medical, Inc.
  • Infusyn Therapeutics, LLC
  • Medallion Therapeutics, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • PAJUNK GmbH Medizintechnologie
  • Teleflex Incorporated
  • tricumed Medizintechnik GmbH
  • Vygon SAS
Product Code: MRR-205091A8875F

The Intrathecal Pumps Market is projected to grow by USD 573.14 million at a CAGR of 5.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 395.76 million
Estimated Year [2026] USD 416.22 million
Forecast Year [2032] USD 573.14 million
CAGR (%) 5.43%

Intrathecal Pumps Executive Summary

Intrathecal pumps are implantable drug delivery systems designed to administer medication directly into the cerebrospinal fluid, enabling targeted therapy at significantly lower doses than many systemic approaches. They are primarily used in the management of severe chronic pain and severe spasticity when oral, transdermal, or injectable therapies are insufficient, poorly tolerated, or associated with unacceptable adverse effects. The intrathecal pump ecosystem spans implantable programmable pumps, catheters, refill kits, clinician programmers, approved drug formulations, surgical implantation workflows, long-term monitoring, and post-implant maintenance. Demand is shaped by the clinical need for precision pain management, neurologic rehabilitation, cancer-related pain control, and alternatives that may reduce reliance on high-dose systemic opioids. Adoption is closely linked to specialist availability, reimbursement pathways, infection prevention standards, device safety surveillance, and multidisciplinary care coordination among pain specialists, neurosurgeons, rehabilitation physicians, pharmacists, and nursing teams. As healthcare systems prioritize personalized medicine and long-term disease management, intrathecal drug delivery is increasingly positioned as a specialized but clinically important intervention for carefully selected patients with refractory symptoms.

Transformative Shifts in the Intrathecal Pump Landscape

The intrathecal pumps landscape is being reshaped by the convergence of precision drug delivery, opioid stewardship, digital health integration, and stronger expectations for long-term device safety. Clinical practice is shifting from broad symptom suppression toward individualized therapy selection, where patient screening, trial dosing, pump programming, and ongoing dose optimization are central to outcomes. Programmable pumps have strengthened the ability to adjust infusion schedules according to symptom patterns, functional goals, and tolerability, supporting more nuanced care for chronic pain and severe spasticity. At the same time, healthcare providers are placing greater emphasis on surgical technique, catheter placement accuracy, refill safety, infection control, and adverse event reporting to reduce complications such as withdrawal, overdose, granuloma formation, catheter malfunction, and device-related infection. Regulatory and clinical scrutiny around implantable devices has encouraged more rigorous post-market surveillance and clinician training. The landscape is also shifting toward integrated care pathways that combine implantation with physical rehabilitation, medication management, behavioral health support, and structured follow-up. These changes are moving intrathecal therapy from a device-centered intervention to a longitudinal care model built around patient selection, safety, adherence, and measurable functional improvement.

Cumulative Impact of Artificial Intelligence on Intrathecal Pumps

Artificial intelligence is beginning to influence the intrathecal pumps ecosystem through clinical decision support, workflow optimization, predictive maintenance concepts, and data-driven patient monitoring. While AI-enabled autonomous dosing is not standard clinical practice, validated analytics can support safer and more efficient care by helping clinicians identify patterns in pain scores, spasticity assessments, refill intervals, adverse event reports, and medication utilization. AI-assisted imaging and surgical planning tools may improve procedural precision by supporting anatomical assessment and catheter placement strategy, particularly in complex spine or neurologic cases. Predictive analytics can also help care teams flag missed refill risks, potential underdosing or overdosing scenarios, and patients who may require closer monitoring due to comorbidities or complex medication regimens. In hospital operations, AI can streamline scheduling for pump refills, inventory planning for implantable devices and sterile supplies, and documentation workflows. However, the impact of AI must be interpreted within strict clinical governance, cybersecurity, interoperability, and regulatory boundaries. Because intrathecal therapy involves high-risk medications delivered near the central nervous system, AI should augment clinician judgment rather than replace it. The most credible near-term value lies in decision support, surveillance, remote monitoring enablement, and quality improvement rather than unsupervised therapy adjustment.

Key Regional Insights for Intrathecal Pumps

In North America, intrathecal pumps benefit from mature pain management and neuromodulation infrastructure, established specialist networks, and a strong emphasis on opioid risk mitigation, particularly in the United States and Canada. Reimbursement complexity and rigorous documentation requirements influence patient access, while safety protocols for controlled substances, refills, and device follow-up remain central to adoption. Europe demonstrates structured use of intrathecal therapy through specialist centers, rehabilitation programs, and national health technology assessment processes, with countries across Western Europe emphasizing clinical appropriateness, cost-effectiveness, and long-term safety evidence. Asia-Pacific is characterized by expanding access to advanced implantable therapies in countries with sophisticated hospital systems, including Japan, Australia, South Korea, China, and India, although adoption varies widely due to differences in reimbursement, specialist availability, urban-rural access, and public-private healthcare capacity. Latin America is developing intrathecal pump adoption through tertiary hospitals and specialist pain centers, with Brazil and Mexico playing important roles; however, affordability, procurement constraints, and uneven access to neurosurgical expertise influence usage. The Middle East is advancing through high-investment hospital infrastructure and specialty care growth, especially in countries with strong medical technology procurement programs, while clinical adoption depends on trained multidisciplinary teams and continuity of follow-up. Africa remains more limited in access, with intrathecal therapy concentrated in select urban referral centers; barriers include device affordability, specialist workforce shortages, maintenance logistics, and limited availability of long-term refill services. Across all regions, the strongest adoption environments are those that combine specialist implantation capabilities with reliable drug supply, reimbursement support, patient monitoring, and structured post-implant care.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, intrathecal pump adoption is shaped by uneven healthcare infrastructure across member states, with more advanced uptake concentrated in tertiary centers that can support neurosurgery, pain medicine, rehabilitation, and device maintenance. The GCC demonstrates comparatively stronger readiness in high-acuity hospital infrastructure, medical technology procurement, and specialty care investment, creating favorable conditions for implantable drug delivery when supported by trained clinicians and long-term refill protocols. The European Union provides a regulated and evidence-driven environment where device safety, clinical evaluation, post-market surveillance, and health technology assessment influence intrathecal therapy access; harmonized medical device rules also strengthen expectations for traceability and safety documentation. BRICS countries represent diverse adoption conditions: China and India are expanding advanced hospital capabilities and specialist services, Brazil supports use through large tertiary systems, while Russia and South Africa face access differences related to geography, procurement, and healthcare delivery capacity. G7 countries generally have the strongest combination of specialist networks, reimbursement mechanisms, regulatory oversight, and clinical research infrastructure, making them important reference environments for intrathecal pump protocols, safety standards, and evidence generation. NATO countries overlap significantly with high-income North American and European health systems, where military and veteran healthcare needs, trauma rehabilitation, chronic pain management, and neurologic injury care can reinforce the relevance of advanced implantable therapies. Across these economic and geopolitical groups, adoption is less dependent on broad population demand and more dependent on the presence of highly trained care teams, reliable device servicing, medication governance, and institutional capacity for lifelong follow-up.

Key Country Insights for Intrathecal Pumps

The United States is a key clinical environment for intrathecal pumps due to its advanced pain medicine, neurosurgery, and rehabilitation networks, alongside strong attention to opioid stewardship and implantable device safety. Canada uses intrathecal therapy within a publicly funded healthcare context where specialist referral pathways, provincial coverage decisions, and access to multidisciplinary pain programs shape adoption. Mexico and Brazil show growing use through tertiary hospitals and private specialty centers, although reimbursement variability and device affordability affect broader access. In the United Kingdom, intrathecal pumps are used within specialist pain and spasticity services where evidence-based referral, clinical governance, and health system resource allocation are important; Germany and France demonstrate structured adoption supported by advanced hospital infrastructure, rehabilitation medicine, and regulatory discipline. Italy and Spain maintain specialist use in pain and neurologic care, with access influenced by regional healthcare administration and hospital procurement processes. Russia has capabilities in advanced neurosurgical and neurologic care in major centers, but geographic scale and healthcare system variation can affect continuity of follow-up. China is expanding access to sophisticated implantable technologies through major urban hospitals and specialist departments, while India's adoption is concentrated in leading private and academic centers where affordability, clinician expertise, and awareness remain decisive factors. Japan has a highly developed medical device environment and aging population needs that support advanced pain and spasticity management, with strong emphasis on safety and clinical quality. Australia benefits from specialist pain services and structured healthcare oversight, although distance and regional access can influence follow-up logistics. South Korea combines advanced hospital systems, digital health readiness, and strong surgical capabilities, supporting selective use of intrathecal pumps in complex pain and spasticity cases. Across all countries, successful intrathecal pump programs require appropriate patient selection, experienced implantation teams, reliable refill access, adverse event monitoring, and coordination between hospital and outpatient care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical safety, patient selection, and long-term care continuity as the core pillars of intrathecal pump strategy. Manufacturers and healthcare stakeholders need to invest in clinician education covering implantation technique, catheter management, pump programming, refill accuracy, infection prevention, and emergency response for overdose or withdrawal events. Product development should focus on reliability, usability, secure programmability, refill safety features, and compatibility with digital monitoring systems that support adherence and follow-up without compromising cybersecurity. Stakeholders should strengthen evidence generation through real-world outcomes, registries, complication tracking, and patient-reported measures that demonstrate functional improvement, quality of life, medication reduction, and care pathway efficiency. Health systems should create standardized intrathecal therapy pathways that include psychological screening, trial protocols, multidisciplinary review, informed consent, refill scheduling, and emergency escalation plans. In emerging markets, leaders should address access barriers through training partnerships, service models that ensure refill continuity, and procurement strategies aligned with hospital capacity. Regulatory and quality teams should maintain robust post-market surveillance, traceability, and adverse event reporting. Commercial strategies should avoid overgeneralizing the therapy and instead focus on high-need, clinically appropriate populations where targeted intrathecal delivery can deliver measurable benefits under expert supervision.

Research Methodology

The research methodology for analyzing the intrathecal pumps landscape should combine clinical evidence review, regulatory assessment, health system evaluation, and expert validation. Primary research should include structured interviews with pain specialists, neurosurgeons, rehabilitation physicians, pharmacists, procurement leaders, clinical engineers, and nursing teams involved in pump refills and patient monitoring. Secondary research should draw from peer-reviewed medical literature, clinical guidelines, regulatory safety communications, device classification documents, hospital protocols, reimbursement policies, public health data, and adverse event reporting systems. Regional and country-level analysis should evaluate specialist availability, surgical infrastructure, controlled substance governance, reimbursement pathways, post-implant follow-up capacity, and patient access barriers. Data triangulation is essential to verify findings across clinical, regulatory, operational, and healthcare delivery sources. The methodology should exclude unsupported assumptions and avoid reliance on promotional claims, instead emphasizing verified evidence related to safety, effectiveness, workflow, and adoption conditions. Because intrathecal therapy involves implantable devices and high-risk medications, assessment should place particular weight on complications, risk mitigation, refill logistics, programming governance, and long-term monitoring. Continuous review is recommended as device regulations, digital health integration, clinical guidelines, and opioid stewardship policies evolve.

Conclusion

Intrathecal pumps occupy a specialized but important role in modern pain and spasticity management by enabling targeted drug delivery for carefully selected patients with severe, refractory symptoms. The sector is advancing through improved programmability, stronger safety expectations, multidisciplinary care pathways, and increasing interest in digital and AI-supported monitoring. Regional adoption remains highly dependent on specialist expertise, reimbursement, hospital infrastructure, medication governance, and the ability to provide reliable long-term follow-up. High-income health systems generally offer more mature implementation environments, while emerging regions present meaningful opportunities when training, affordability, and service continuity are addressed. The most sustainable path forward is not broad indiscriminate expansion, but evidence-based deployment in patients most likely to benefit under expert clinical supervision. Industry leaders that prioritize safety, real-world evidence, interoperability, clinician training, and patient-centered care will be best positioned to support responsible growth in intrathecal drug delivery. As healthcare systems continue to seek precise alternatives for complex pain and neurologic conditions, intrathecal pumps will remain a critical technology within advanced, multidisciplinary treatment strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Intrathecal Pumps Market, by Pump Type

  • 7.1. Introduction
  • 7.2. External Pumps
  • 7.3. Implantable Pumps
    • 7.3.1. Programmable
    • 7.3.2. Constant-Flow

8. Intrathecal Pumps Market, by Drug Type

  • 8.1. Introduction
  • 8.2. Baclofen-Based Therapy
  • 8.3. Non-Opioid Analgesic Therapy
  • 8.4. Opioid-Based Therapy
  • 8.5. Multi-Agent Compounded Therapy

9. Intrathecal Pumps Market, by Reservoir Capacity

  • 9.1. Introduction
  • 9.2. Less Than 20 ML
  • 9.3. 20 ML To Less Than 30 ML
  • 9.4. 30 ML To Less Than 40 ML
  • 9.5. 40 ML And Above

10. Intrathecal Pumps Market, by Therapy Area

  • 10.1. Introduction
  • 10.2. Pain Management
    • 10.2.1. Cancer Pain
    • 10.2.2. Chronic Noncancer Pain
  • 10.3. Spasticity Management
    • 10.3.1. Cerebral Palsy
    • 10.3.2. Multiple Sclerosis
    • 10.3.3. Spinal Cord Injury

11. Intrathecal Pumps Market, by Procedure Type

  • 11.1. Introduction
  • 11.2. Screening Trial Procedures
  • 11.3. New Implant Procedures
  • 11.4. Replacement Procedures
  • 11.5. Revision Procedures
  • 11.6. Explant Procedures

12. Intrathecal Pumps Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Intrathecal Pumps Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Intrathecal Pumps Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. ASEAN
  • 14.6. GCC

15. Intrathecal Pumps Market, by Country

  • 15.1. United States
  • 15.2. China
  • 15.3. Germany
  • 15.4. Japan
  • 15.5. India
  • 15.6. United Kingdom
  • 15.7. France
  • 15.8. Canada
  • 15.9. Australia
  • 15.10. Brazil
  • 15.11. Italy
  • 15.12. Mexico
  • 15.13. South Korea
  • 15.14. Russia
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. B. Braun SE
  • 17.2. Baxter International Inc.
  • 17.3. Becton, Dickinson and Company
  • 17.4. Boston Scientific Corporation
  • 17.5. CODAN Medizinische Gerate GmbH & Co KG
  • 17.6. Eitan Medical Ltd.
  • 17.7. Epimed International, Inc.
  • 17.8. ICU Medical, Inc.
  • 17.9. Infusyn Therapeutics, LLC
  • 17.10. Medallion Therapeutics, Inc.
  • 17.11. Medtronic plc
  • 17.12. Micrel Medical Devices S.A.
  • 17.13. Moog Inc.
  • 17.14. PAJUNK GmbH Medizintechnologie
  • 17.15. Teleflex Incorporated
  • 17.16. tricumed Medizintechnik GmbH
  • 17.17. Vygon SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRATHECAL PUMPS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INTRATHECAL PUMPS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INTRATHECAL PUMPS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INTRATHECAL PUMPS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INTRATHECAL PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL INTRATHECAL PUMPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL INTRATHECAL PUMPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTERNAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTERNAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTERNAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROGRAMMABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROGRAMMABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROGRAMMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONSTANT-FLOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONSTANT-FLOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONSTANT-FLOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACLOFEN-BASED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BACLOFEN-BASED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACLOFEN-BASED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-OPIOID ANALGESIC THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-OPIOID ANALGESIC THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-OPIOID ANALGESIC THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPIOID-BASED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPIOID-BASED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPIOID-BASED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MULTI-AGENT COMPOUNDED THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MULTI-AGENT COMPOUNDED THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MULTI-AGENT COMPOUNDED THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LESS THAN 20 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LESS THAN 20 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LESS THAN 20 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 20 ML TO LESS THAN 30 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 20 ML TO LESS THAN 30 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 20 ML TO LESS THAN 30 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 30 ML TO LESS THAN 40 ML MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 30 ML TO LESS THAN 40 ML MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 30 ML TO LESS THAN 40 ML MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 40 ML AND ABOVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 40 ML AND ABOVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 40 ML AND ABOVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CANCER PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CANCER PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CANCER PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CHRONIC NONCANCER PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CHRONIC NONCANCER PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHRONIC NONCANCER PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPASTICITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CEREBRAL PALSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CEREBRAL PALSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CEREBRAL PALSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPINAL CORD INJURY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SCREENING TRIAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SCREENING TRIAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SCREENING TRIAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEW IMPLANT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEW IMPLANT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEW IMPLANT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REPLACEMENT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REPLACEMENT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REPLACEMENT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REVISION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REVISION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REVISION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXPLANT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EXPLANT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXPLANT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. NATO INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. NATO INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 157. NATO INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 158. NATO INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. NATO INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 160. NATO INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. G7 INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 165. G7 INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 168. G7 INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. G7 INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GCC INTRATHECAL PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GCC INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 205. GCC INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 208. GCC INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 209. GCC INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. GCC INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL INTRATHECAL PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GERMANY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. JAPAN INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 246. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 248. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 249. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. JAPAN INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. INDIA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. INDIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. INDIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 256. INDIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. INDIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 258. INDIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 259. INDIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. FRANCE INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 281. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. FRANCE INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 296. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 300. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 301. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. AUSTRALIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. ITALY INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. ITALY INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. ITALY INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 316. ITALY INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 328. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 329. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 330. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 331. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. MEXICO INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 336. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 341. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. SOUTH KOREA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 348. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 349. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. SPAIN INTRATHECAL PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY IMPLANTABLE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 356. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY RESERVOIR CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 358. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
  • TABLE 359. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 360. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY SPASTICITY MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 361. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 362. SPAIN INTRATHECAL PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 363. GLOBAL INTRATHECAL PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 364. GLOBAL INTRATHECAL PUMPS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025